Participants 81 99 6
patients with AIDS
Participants 226 281 4
patients with acquired immunodeficiency syndrome (AIDS)
Participants 585 680 6
(165-microg/injection [35 eyes, 30 patients] and 330-microg/injection [153 eyes, 120 patients])
